Authors:
Hoomans, EHM
Andersen, AN
Loft, A
Leerentveld, RA
van Kamp, AA
Zech, H
Citation: Ehm. Hoomans et al., A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon (R)) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP (R)) in a fixed-dose regimen in women undergoing ovarian stimulation, HUM REPR, 14(10), 1999, pp. 2442-2447